The Defense Health Agency (DHA) intends to modify the Master Ceiling Limit on Blanket Purchase Agreement (BPA) N6264521A0003 under the authority of 41 U.S.C. 1901 with the American National Red Cross (ARC), 431 18th Street, Washington, DC, 20006-5310, for the provision of blood products and related services for the Naval Medical Center Portsmouth, VA (NMCP). The ordering period is from 01 October 2021 through 30 September 2024.

To meet the needs of the Military Treatment Facility (MTF) the Master Ceiling Limit of N6264521A0003 will increase from $1,500,000.00 to $2,500,000.00. As a Level II Trauma Center, the reliance on blood products and blood testing offered by The American Red Cross (ARC) is extensive. The requirement is to provide blood products and reference laboratory testing in support of laboratory operations to NMCP’s Laboratory Medicine Services. The Contractor shall be registered with the Food and Drug Administration (FDA), accredited by the Association for the Advancement of Blood & Biotherapies (AABB), and comply with continuous Current Good Manufacturing Practices (CGMP) as outlined by the International Society for Pharmaceutical Engineering (ISPE). Blood products needed include packed red blood cells, apheresis, platelets, fresh frozen plasma, cryoprecipitate, liquid plasma, low titer whole blood, etc. Products are required on both a standard and emergent basis. Blood and blood products shall be provided to NMCP Monday through Sunday, twenty four (24) hours a day, including all Federal holidays. Delivery time frames are as follows: within two (2) hours of the request for routine and products with special requirements, and within one (1) hour of the request for emergent products and no special requirements. Reference laboratory services include antibody identification, antibody screenings, Rh typing, etc. Testing is required on both a standard and emergent basis. Test results shall be reported within the following time frames:

STAT: One (1) hour, ASAP: Two (2) hours Routine: Eight (8) hours. Test results may exceed time frame requirements depending upon complexity of the testing required and may take several hours to several days.

Required Products/Service:

Leukoreduced Red Blood Cells

Apheresis Platelets – PAS, LVDS

Apheresis Platelets-PAS Pathogen Reduced

Plasma

Fresh Frozen Plasma

Cryoprecipitate

Cryoprecipitate, Pooled

Irradiation (RBC & SDP)

Autologous Fee

Directed Fee

Frozen Fee

Deglycerolization

Washed Product

O negative Red Cell

O positive Red Cell

AB Plasma

AB Cryo

AB Cryo Pools

STAT Service Processing

Delivery Fee

Liquid Plasma (per unit)

Low titer whole blood type O+

Low titer whole blood type O-

Non-LR CPDA-1 LTOWB

Laboratory Services:

HLA STAT Product, routine hours

HLA STAT Product, non-routine hours

HLA STAT Sample, Routine Hours

PLATELET CROSSMATCH, PERTEST

HLA; SINGLE ANTIGEN

HLA; SINGLE ANTIGEN

HLA; ANTIBODY SCREENING

PLATELET ANTIBODY SCREEN

HLA-A (INTERMED RESOLUTION)

HLA-B (INTERMED RESOLUTION)

RBC Ag neg 1 per unit

RBC Ag neg 2 per unit

RBC Ag neg 3 per unit

RBC Ag neg 4 per unit

RBC Ag neg 5 per unit

Hist Ag inquiry/unit

RBC Ag neg 6 per unit

RBC Ag neg 7 per unit

RBC Ag neg 8 per unit

RBC Ag neg 9 per unit

Hist Ag/Ag NT/each Ag

Molecular type/each Ag

Plt Ag neg not HPA-1a IRL

PLT Component, crossmatch

PLT Ab per test, IRL

Platelet antibody, ELISA/Flowcytometry, IRL

Platelet Associated Ig (Direct)

ARDP high rare Ag/unit

Hemoglobin S, per test

Rare/uncommon pheno/unit

Ag Screen-pt serum/unit

Ag Scrn, spec order 11-20

Ag Scrn, spec order 21-30

Ag Scrn, spec order 31-40

Ag Scrn, spec order 41-50

Ag Scrn, spec order 51-60

Ag Scrn, spec order 61-70

Special Recruitment Prod

IgA deficient component

IgA Testing

Monocyte Monolayer Assay

STAT Ag order routine hrs

STAT Ag order non-rtn hrs

STAT IRL sample, routine hours

Antibody Screen, each media

Elution, each

Ab ID/each panel each media

DAT, each antisera

Indirect titer, per Ab

Rh(D)Type

Rh Phenotyping, (C c E e)

Pre-Rx RBCs w/chemicals/drugs, per cell

Separation by density gradient, retics

Complex prep of pt cells for adsorption

Thawing rare reagent red cells, per cell

Transfusion Service tagging, PLT, IRL

Immediate Spin crossmatch

AGT phase of crossmatch

Frozen plasma thawing

81403 RHD SNP detection by RFLP

81403 RHCE SNP by RFLP

81403 RHD Zygosity PstI PCR RFLP

81403 Multiplex PCR, partial RHD

Multiplex PCR, Big C, Little C, RHDPsi, exon 4 and 7

NML Sample, Urgent, routine hours

81403 Sanger Sequencing, 6-10 exonsRHCE

HPA Panel (replaces HP15,HPA2,3,4,5,6,9)

81403x2 Full RH genotyping

Anti-CMV negative, per test

RBC Ag neg 1 per unit

Historic HgbS per unit

Unit search fee for RBC

Special Antiglobulin Test

STAT IRL sample after hours

Ab ID, each selected reagent cell

ABO Type

RBC Ag, other than ABO or D, each

Differential/Auto Ads, each adsorption

Complex Red Cell Antibody Identification

Unit Less than 14 Days

Unit Less than 48 Hours

Unit Less than 5 Days

Unit Less than 6 Days

Pedi Unit

This notice of intent is not a request for competitive proposals and no solicitation document exists for the

requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information, or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source modification.

Capability statements are due by 8:00 AM Local Time, 25 March 2024. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: kathleen.s.gorelick.civ@health.mil.

IN SUBJECT LINE REFERENCE: "N6264521A0003 Master BPA Ceiling Increase"

Attachments/Links